视频丨陈泽锴 中成药再次站上了风口浪尖。 曾经说明书上那些模棱两可的"尚不明确"，即将成为历史，而中成药行业也在加速"低质"出清，产业升 级持续。 北京中医药大学卫生健康法学教授邓勇向21世纪经济报道记者表示，距2026年7月1日《中药注册管理专 门规定》第七十五条落地仅剩半年，中成药行业正迎来监管与市场的双重变革，行业洗牌与转型升级全 面加速。 邓勇向记者指出，当前政策倒计时已对行业产生显著影响。大量中成药批文存在安全信息标注缺失问 题，企业主动注销、转让低价值批文的现象增多，监管部门密集发布说明书修订公告，合规压力持续攀 升。补齐品种毒理、临床真实世界数据等合规成本高昂，叠加生产监管新规实施，行业合规成本大幅上 涨。 同时，渠道端采购与招标倾向合规品种，低质产品市场空间持续被挤压。 根据本报此前报道，2026年7月1日，根据国家药监局规定，届时说明书上【禁忌】【不良反应】等关键 安全信息若仍标注"尚不明确"，药品将面临退市。 中国工程院院士张伯礼也对此向《科技日报》进行了回应，从近5年国家药品不良反应/事件报告看，中 药占12%，化学类药物占81%，中药相对安全。该规定的出台，核心目的是补齐中成药说明书安 ...

Core Viewpoint - The article discusses the key focus areas for the national medical insurance system in China for 2026, emphasizing the goal of making childbirth essentially free nationwide and enhancing the overall management and efficiency of medical insurance funds [1][4]. Group 1: Key Focus Areas for 2026 - The national medical insurance system will focus on consolidating universal coverage and improving the basic medical insurance system [1]. - There will be support for the development of commercial health insurance to establish a multi-tiered medical security system [1]. - Strengthening the management of medical insurance funds to ensure their safety is a priority [1]. Group 2: Childbirth Cost Reduction - The initiative aims for childbirth to be essentially free across the country by 2026, with specific measures to include flexible employment workers and migrant workers in maternity insurance coverage [4]. - Seven provinces, including Jilin, Jiangsu, and Shandong, have already achieved the goal of making childbirth free [4]. - The plan includes enhancing prenatal care coverage and ensuring direct payment of maternity benefits to insured individuals [4]. Group 3: Long-term Care Insurance Development - The long-term care insurance system currently covers approximately 300 million insured individuals and has benefited over 3.3 million disabled individuals [5]. - The focus will be on optimizing long-term care services and encouraging commercial insurance institutions to develop related products [5]. Group 4: Fund Management and Efficiency - The article highlights the importance of the proper use of medical insurance funds, which are crucial for public health [8]. - Measures have been taken to combat fraud, with approximately 120 billion yuan recovered over five years [8]. - The implementation of a new payment system and the promotion of real-time settlement of medical insurance funds are planned for 2026 [10]. Group 5: Drug Procurement and Innovation - The national centralized drug procurement has become a regular practice, with the latest round including 55 drugs aimed at stabilizing clinical use and ensuring quality [12]. - The introduction of a commercial insurance drug directory aims to cover innovative drugs that exceed basic insurance coverage [13]. - The focus on digitalization and artificial intelligence in medical insurance governance is expected to enhance policy implementation and industry vitality [14][15].